These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20940623)

  • 21. Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study.
    Waldeyer C; Seiffert M; Staebe N; Braetz J; Kohsiack R; Ojeda F; Schofer N; Karakas M; Zeller T; Sinning C; Schrage B; Westermann D; Sydow K; Blankenberg S; Brunner FJ; Schnabel RB
    Clin Ther; 2017 Nov; 39(11):2311-2320.e2. PubMed ID: 29103665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of methods for the measurement of low-density lipoprotein cholesterol.
    Bairaktari ET; Seferiadis KI; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):45-54. PubMed ID: 15821838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid attainment among patients newly treated with lipid-altering drugs.
    Hess G; Chang CL; Chung K
    Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How should low-density lipoprotein cholesterol concentration be determined?
    Faas FH; Earleywine A; Smith G; Simmons DL
    J Fam Pract; 2002 Nov; 51(11):972-5. PubMed ID: 12485554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
    Whelton SP; Meeusen JW; Donato LJ; Jaffe AS; Saenger A; Sokoll LJ; Blumenthal RS; Jones SR; Martin SS
    J Clin Lipidol; 2017; 11(4):1065-1072. PubMed ID: 28826567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
    Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.
    González CA; Rubio-Guerra AF; Pavía A; Redding FJ; Cervantes JL; Zacarías JL; Yza R; Carranza J; Fernández P; Morales E; Robles FJ; Leyva JL; Rodríguez L
    Clin Drug Investig; 2007; 27(5):333-7. PubMed ID: 17451281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid management for the prevention of cardiovascular disease.
    Schaefer JR
    Curr Pharm Des; 2011; 17(9):852-60. PubMed ID: 21418030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.
    Martin SS; Giugliano RP; Murphy SA; Wasserman SM; Stein EA; Ceška R; López-Miranda J; Georgiev B; Lorenzatti AJ; Tikkanen MJ; Sever PS; Keech AC; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2018 Aug; 3(8):749-753. PubMed ID: 29898218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level.
    Lindsey CC; Graham MR; Johnston TP; Kiroff CG; Freshley A
    Pharmacotherapy; 2004 Feb; 24(2):167-72. PubMed ID: 14998216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Low-Density Lipoprotein Cholesterol Concentrations by Direct Measurement and by Friedewald Calculation.
    Sung KC; Kwon CH; Lee MY; Kwon MJ; Lee JH; Jung MH; Shin JH
    Am J Cardiol; 2020 Mar; 125(6):866-873. PubMed ID: 31928718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.